Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
ZonMw investeert in verbeteren leefstijl na beroerte
jan 2024 | Myocardinfarct, Neuro-vasculair